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 Acute asthma exacerbation commonly leads to a visit to the emergency 
department.  One study reports 2,000,000 emergency visits per year for acute asthma 
exacerbations. (45) Many of the patients who present with this complaint are also 
smokers; recent research indicates percentages in the 17-25% range. (6,46) Furthermore, 
they often have little or no follow-up care and often rely only on the emergency 
department for their health care needs.  Therefore, the burden falls on the staff in the 
emergency department to treat the patient’s immediate problem of the acute exacerbation, 
and also to provide ways to help the patient with long term secondary prevention of 
asthma. 
Research has been done that indicates that smoking worsens the course of asthma.  
Smoking increases airway reactivity to irritants and causing an acceleration in the rate of 
pulmonary dysfunction that is irreversible. (8,9)  When compared to asthma patients that 
do not smoke, smoking asthmatics have more respiratory symptoms as well as more 
severe asthma as evidenced by lower forced expiratory volume in the first second to 
forced vital capacity (FEV(1)/FVC) ratio, lower lung diffusion ratio, and more 
radiological evidence of lung damage.  This evidence includes both airway and lung 
parenchymal damage visible on high resolution computed tomography (CT) scan. (10) In 
direct comparison with former-smokers and never-smokers, asthmatic active smokers 
have much higher severity scores. (11) Another theory of smoking asthmatics is that they 
may have a different phenotype than their nonsmoking counterparts.  These differences 
include the type of airway cells present and the mediators involved, as well as a lack of 
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response to inhaled corticosteroids.    The increased severity of asthma symptoms in 
smokers may be attributed to this resistance to corticosteroids, as this is part of the 
routine treatment for asthma.(12)   Furthermore, mere exposure to environmental smoke 
by nonsmoking asthmatics causes more severe asthma as evidenced by more frequent 
emergency department visits and more frequent use of asthma controlling medications. 
(13,14) One recent study has also determined that smoking cessation improves lung 
function as well as causing improvement in measurement of sputum neutrophil count 
following only six weeks of smoking cessation. (15)  This study looked at the short term 
outcomes of smoking cessation on acute asthma.  Specifically, the effect on a patient’s 
asthma as measured by return visits, medication use, and peak flow measurements.   
 Several factors make this project a viable research study to investigate the 
possible effects of more active intervention for smoking cessation in asthmatics who 
present to the emergency department with an acute exacerbation.  One of these is the well 
documented fact that smoking is a major cause of illness, disability, and emergency 
department visits.  From 1995-1999 alone, smoking accounted for over 440,000 
premature deaths.  In addition, for the 22 billion packs of cigarettes sold in 1999, $3.45 
per pack was spent on medical care that was attributed to smoking and an additional 
$3.73 per pack was the result of lost productivity. (1) Although approximately 25 % of 
the population smokes, a reported 48% of the emergency department patient population 
are smokers. (2,3)  Furthermore, patients who present to the emergency department for a 
smoking-related illness score significantly higher on the Fagerstrom Test for Nicotine 
Dependence than do patients presenting for non-smoking-related illness. (4,5) 
5 
In emergency department patients, smoking seems to worsen many different 
illnesses.   In one study, only 42% of the asthmatics presenting with an acute 
exacerbation did not smoke, or had never smoked. (6) Furthermore, respiratory illnesses 
are not the only ones in which smoking makes an impact.    Another common diagnosis 
in the emergency department is acute myocardial infarction (AMI).  Smoking is 
considered to be one of the most important preventable causes of AMI. (7)  
Despite the fact that such a high percentage of emergency department patients are 
smokers and that many of their illnesses are worsened by their smoking, counseling on 
smoking cessation and/or smoking cessation therapy are not part of standard emergency 
care. (2) Efficacious application of nicotine replacement therapy (NRT) requires the 
concurrent use of counseling. (28) This project will study a targeted group of emergency 
department patients to determine if counseling coupled with free NRT therapy is an 
effective method of promoting smoking cessation in the asthmatics presenting with an 
acute exacerbation. 
Another concept important for the completion of this project is the fact that the 
emergency department is an appropriate site to initiate smoking cessation.  The 
emergency department population is unique because of the fact that a large proportion of 
the patients do not have access to primary or preventative medical care.  Patients seen in 
the emergency department for care of their asthma are not there for maintenance, but 
rather for “crisis oriented care”.  These patients also tend to be of lower socioeconomic 
status and have less medical knowledge than their counterparts in the primary care 
setting. (29) 
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Although the emergency department is a challenging environment in which to 
offer preventative health, there is an evolving role as more and more patients begin to use 
the emergency department as their sole source of medical care.    The current standard of 
care requires asking all patients about smoking status.  In one study, 56% percent of 
patients were verbally screened for smoking.  However, only 56% of those conversations 
with patients involved advice to begin smoking cessation. 16% involved assessing 
readiness to quit and an even smaller percentage, 13%, involved a referral to help with 
smoking cessation. (30) Another study indicates that only 20-34% of emergency 
physicians engage in smoking cessation counseling with their patients in the emergency 
department. (31)  The lack of preventive care offered, does not seem to be due to a lack 
of interest on the part of the patients.   In one study, 96% of the patient population in the 
emergency department expressed interest in some type of preventive health care, 
including help with smoking cessation. (32) Another study presented evidence that, not 
only are certain emergency department patients interested in counseling and advice on 
smoking cessation,  but they were also willing to spend an extra 15 minutes in the 
emergency department to obtain the counseling. (33) 
In a study that looked at factors contributing to the success of smoking cessation 
in hospitalized patients, being in the hospital itself was an independent predictor of 
success (34).  This data supports the idea of a “teachable moment”, where patients are 
directly aware of the negative consequences of their smoking habits.   Other studies show 
that smokers respond well to counseling in the hospital environment. (35,36) 
It is accepted that nicotine replacement therapy is effective.  NRT has been 
available for many years and found to be an effective treatment for smoking 
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cessation.(16)  Although all forms of NRT have been shown to be equally effective(17), 
recent work indicates that a combination of nicotine delivery systems may be more 
effective than any monotherapy.  In certain situations, combination NRT has greater 
efficacy in successful smoking cessation as well as relief of withdrawal symptoms.(18) 
U.S. Public Health Service guidelines for clinical practice encourage the use of the 
nicotine patch along with a self-administered form of nicotine replacement. (19) 
There have been several recent studies looking at the efficacy of programs that 
offer free NRT as a way to promote smoking cessation.  Although NRT in its different 
forms and doses is widely available without a doctor’s prescription, cost of therapy has 
been a barrier to many patients using NRT.  In one study in which a quitline was used to 
distribute free nicotine patches, it was noted that the number of calls to that quitline 
increased dramatically after it became known that the patches were available.  Smokers 
who received the free NRT had higher quit rates than those who did not.  This study 
showed that offering free NRT is both a highly efficacious and cost-effective way to 
promote smoking cessation.(21) A twelve month follow-up to this study demonstrated the 
quit rate to be 1.78 times higher for those smokers who received the free patches as 
opposed those who did not, even when factoring in the efficacy of the support of the 
quitline.(20)  
Part of this research plan is to use a Brief Motivational Interview (BMI) along 
with NRT to promote smoking cessation.  The patients included in this study are in a  
situation susceptible to intervention for smoking cessation because they presented to the 
emergency department with an acute exacerbation of a respiratory problem with known 
links to cigarette smoking.  These patients presented in a “teachable moment”: when they 
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were more receptive to smoking cessation counseling.  Counseling has remained in the 
realm of the primary care provider and it is not currently standard of care for emergency 
physicians to provide counseling to these patients.  One study revealed that even though a 
majority of patients in the emergency department reported being receptive to smoking 
cessation counseling, only 50% were advised to quit, and 9% were offered any type of 
assistance. (22)   
Despite the lack of counseling taking place, there is strong evidence that it has 
great potential.  Brief interventions have been successful in increasing quit rates in 
hospitalized patients. (23) However, this technique has not been evaluated for smokers 
who present to the emergency department. 
BMI is a brief 5-10 minute counseling session that has been used successfully to 
reduce alcohol consumption in both clinic (24,25) and emergency department (26,27) 
populations.  BMI is a patient centered approach that uses motivational enhancement 
techniques.  In this study, providers were able to use the motivation provided by the 
patient’s presentation to the ED with an acute respiratory illness requiring medical 
intervention.  Patients were able to draw motivation from the negative consequences of 
their smoking. 
The intervention used in this study was a combination of NRT and BMI.  There is 
evidence that the use of counseling in conjunction with NRT has a higher quit rate than 
NRT alone for patients in an inpatient hospital setting. (28) The emergency department is 
a challenging setting where the brief, formatted approach of the BMI is particularly 
appropriate.  Because BMI with or without NRT is not standard of care, this project was 
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set up to compare the effectiveness of BMI and combined NRT with the current standard 
of care. 
  
By utilizing all of these factors as part of the study, this research looked into a 
particular area of smoking cessation to provide a viable and effective way to encourage 
asthmatic patients in the emergency department to quit.  Given the evolving nature of 
care in the emergency department due to the limited access of ED patients to primary 
care along with the opportunity of a “teachable moment” due to the acute respiratory 
distress, this study was designed to demonstrate an efficacious and practical way to 
encourage smoking cessation in the emergency department.   
 
Statement of Purpose 
The purpose of this research is to evaluate the short term effectiveness of the use 
of more active intervention in helping asthmatics who present to the emergency 
department with an acute exacerbation to quit smoking.   Currently, most people who 
present to the emergency department with an asthma exacerbation are asked about their 
smoking habits; however, that is usually where the conversation ends.  Some patients are 
advised to quit smoking, but there are very few who are actually formally counseled.  
There are even fewer who are offered help with smoking cessation, whether it is a referral 
to a quitline, nicotine replacement, or pharmacological intervention.   The first hypothesis 
for this study is that by using Nicotine Replacement Therapy (NRT) coupled with a Brief 
Motivational Intervention (BMI) there will be a higher rate of smoking cessation in this 
population versus the standard care provided in a typical emergency department visit for 
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acute asthma exacerbation.  Furthermore, participants in the NRT/BMI group will have a 
reduction in the number of cigarettes smoked per day.   
This study is targeting a specific subset of emergency department patients; 
smokers presenting with an acute asthma exacerbation.  A good percentage of these 
patients are aware that their smoking may impact their asthma symptoms.  However, they 
may not have previously attempted to quit.  There is a great deal of research about 
smoking and asthma.  The second hypothesis of this study is that the group that received 
the NRT/BMI will have greater improvement of their asthma symptoms when compared 
to the group that received standard care.  This was measured using the number of return 
visits for asthma, peak flow, and medication requirements. 
The primary aims of the study are as follows: 
1.  To evaluate the effectiveness of NRT /BMI for increasing rates of smoking 
cessation in Emergency Department patients presenting with acute exacerbations 
of asthma as measured by carbon monoxide levels, and self-reported tobacco use. 
2.  To assess the effectiveness of NRT/BMI in improving asthma outcomes as 
measured by peak expiratory flow rates, unscheduled medical visits for asthma, 
and medication requirements.   
The secondary aim of this study was to evaluate the effectiveness of NRT/BMI in 
reducing cigarette consumption among asthmatic smokers.   
 
Methods 
 The methods described for this study were submitted and approved through the 
Human Investigations Committee in May 2005.  Patient enrollment began in July 2005. 
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Patient screening and enrollment was accomplished by the clinical team caring for 
patients or one of the investigators.  Any patient presenting to the emergency department 
with an acute asthma exacerbation, who was not likely to be admitted, and was a smoker 










The Stage of Change questionnaire is used to assess the patient’s readiness to actually 
quit smoking.  Patients are divided into one of three stages of change based on the 
answers given to the three questions.  These stages are precontemplation, contemplation, 
and preparation. The precontemplation stage is when the patient is not aware that their 
smoking is problematic.  In the contemplation stage, the patient is aware that their 
smoking is problematic and have begun to think seriously about quitting.  However, in 
this stage, the patients have not yet committed to take action and begin a smoking 
cessation program.  In the preparation stage of change, the patient is intending to take 
action within the next 30 days to begin a smoking cessation program.   
The inclusion criteria is as follows: 
Table 1: Stage of Change Questionnaire 
Stage of Change 
 
1. Are you currently a smoker? 
2. In the last year, how many times have you quit smoking for at least 
24 hours? 
3. Are you seriously thinking of quitting smoking? 
a. Yes, within the next 30 days. 
b. Yes, within the next 6 months 
c. No, not thinking of quitting. 
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1. Presentation to emergency department with an acute asthma exacerbation 
2. Age 18-50 years 
3. Previously diagnosed with asthma 
4. Current smoker > 10 cigarettes/smoking day 
5. Contemplation or Preparation stage of change 
The exclusion criteria is as follows: 
1. Previous adverse reaction to nicotine replacement or adhesives 
2. Admitted to hospital this visit 
3. Recent acute myocardial infarction or unstable angina 
4. Acute psychiatric illness 
5. Chronic Obstructive Pulmonary Disease (COPD) 
6. Pregnancy/breast feeding (based on self report, or on ED urine testing 
when appropriate) 
7. Currently in smoking cessation program 
8. Currently taking nicotine replacement therapies (NRTs) 
9. Currently taking Buproprion (as Zyban or Wellbutrin preparations) 
10. Severe hypertension (SBP > 160) 
11. Unstable arrhythmia 
12. Not proficient in spoken and written English 
13. Prisoners 
14. Cognitively impaired (as determined by evaluating physician) 
15. Concurrent use of drugs of abuse 
16. Unstable psychiatric condition 
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Once a patient was deemed eligible for inclusion, their informed consent was 
obtained, and the patient was enrolled in the study.  Subject numbers were randomly pre-
assigned to either the nicotine or the control study groups.  Each enrollee received a 
consecutive subject number that determined to which study group they would belong.  
Both groups received a smoking history inventory.  This smoking history inventory 
included demographic information, age at first cigarette, age daily smoking began, 
number of days per week patient smokes, number of cigarettes per day, length of time for 
current smoking habits, brand of cigarette most commonly smoked, use of other tobacco 
products, how deeply the patient inhales, smoking habits of others in the household, 
smoking status of spouse or significant other, children in the household and concern of 
second hand smoke, time since last cigarette, most important cigarette of the day.  Other 
questions dealt with the patient’s asthma history including previous history of acute 
asthma exacerbations along with treatment, use of asthma medications, and severity of 
this acute asthma exacerbation.  
Asthma treatment for both groups followed a standard emergency department 
protocol for acute asthma exacerbations based on the British Thoracic Society guidelines. 
(44) In addition, exhaled carbon monoxide measurements were taken.  Carbon monoxide 
gas is found in cigarette smoke, and exhaled carbon monoxide levels measured in parts 
per million (ppm) are often used to verify a patient’s self-reported smoking status.  There 
is a great deal of research into the appropriate cutoff for carbon monoxide level to 
appropriately correlate with smoking status; however, a commonly accepted value is > 6 
ppm. (47) 
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   Follow-up for both groups took place at 7 days in the Urgent Care section of the 
emergency department and by telephone at 30 days.  The 7-day follow-up involved a 
self-reported Follow-up Assessment that asked about smoking since discharge from the 
emergency department, use of NRT, side effects of NRT, return trips to the emergency 
department for asthma treatment, hospitalizations for asthma since discharge, current 
asthma severity, and use of asthma medications since discharge.  At the time of the 7-day 
follow-up visit a repeat peak flow measurement and exhaled CO level measurement were 
obtained.  The 30-day telephone follow-up involved only the Follow-up Assessment.   
Three of the patients who were unable to make it back to urgent care for their 7-
day follow-up were contacted by phone instead.  These included 2 members of the 
standard care group and one member of the NRT/BMI group. Patients were asked to 
repeat a peak flow measurement at home and report it.  No CO level measurements were 
obtained for these patients. 
The control group received standard care which involved advice to stop smoking.  
There was no formal counseling or referral to a smoking cessation program in this group. 
The nicotine group received a standardized Brief Motivational Interview, as well as 
nicotine replacement therapy (NRT). For this study NRT consisted of a 7 day supply of  
21 mg  patches as well as 2 mg lozenges.   Patients also received instructions on the use 
of the nicotine patches and lozenges.   At the 7-day follow-up visit, subjects who found 
NRT useful, were offered an additional 3 week supply of patches and lozenges. 
Statistical considerations included measurement of differences in proportions 
betweens groups using Fischer’s exact test.  These differences included stage of change, 
return visit for asthma, and presence of other smokers in the home.  Differences between 
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group means were tested for significance using the two-sided Student t-test.  These 
included number of years smoking, cigarettes per day, number of days per week patient 
smokes, self-reported severity of asthma symptoms, and peak expiratory flow upon 
presentation to the emergency department.  One question dealt with time to first cigarette 
of the day. This question was asked with a time range.  Using the midpoint of the range 
given, the mean time to the first daily cigarette was calculated for each of the two groups. 
The self-reported severity of asthma was determined by asking the patients to rate the 
severity of their asthma symptoms on a scale of 0-10.  For this scale, 0 is absolutely no 
asthma symptoms and 10 being the worst asthma symptoms that the patient had ever 
experienced. 
The results were analyzed as follows: The severity of asthma at 7 and 30 days, the 
weekly use of inhalers, and peak flow measurements at 7 and 30 days were compared 
using the student t-test.  The Fisher exact test was used to analyze if participants required 
a return visit or not and whether there was a subjective improvement in their asthma 
symptoms or not. 
The proportion of subjects abstaining from tobacco for one week was defined as 
negative self report and a CO level < 10 ppm.  One week quit rates are not widely 
reported.  A six week rate of 50% for counseling and combined NRT has been 
reported.(38) Using a two sided Fischer’s exact test and assuming a quit rate of 10% for 
the control group and 40% for the NRT/BMI group and setting ά=0.05 yields a power of 
80% with n = 36 per group. 
For the purposes of this study a successful quit at the 7-day follow-up was defined 
as 6 consecutive days of no cigarettes prior to the 7-day follow-up.  For the 30-day 
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follow-up, a successful quit was defined as 29 days of no cigarettes prior to the 30-day 
follow-up.  Also, a successful reduction in cigarettes is defined as at least 25% fewer 
cigarettes smoked per day.  The quit data as well as the reduction data was analyzed 
using the Fisher’s exact test. 
Participants in both groups who followed-up received a $20 stipend to 
compensate for their time.  Participants were paid after completing the requirements of 
the 7-day follow-up. 
My involvement included assisting in the development of the initial smoking 
history inventory, 7-day, and 30-day Follow-up Assessment.  I also participated in the 
screening, enrollment, and follow-up (7 and 30-day) of several test subjects.  I completed 
the statistics presented in this thesis. 
Results 
Demographics 
Patient enrollment began in July 2005 and continued through October 2006.  
During this time, a total 23 patients were enrolled in the study.  The demographics 
included 15 women and 8 men.  Among the patients enrolled 40% were Hispanic, 43% 
were African American, and 17% were Caucasian. (n = 23) Of the total number of 
patients enrolled in the study, 12 participants were randomly assigned to the control 
group (standard care) and 11 participants were randomly assigned to the Nicotine/BMI 
group. The randomization was performed as part of the study design and prior to the 
enrollment of the first patient in the study. 
Although there were 23 patients enrolled in the study, 9 of the original patients 
were lost to follow-up before returning for the 7 day follow-up.  This left 14 patients in 
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the study.  The 14 remaining patients were divided evenly among the two participant 
groups.  7 of the remaining participants were part of the standard care group and 7 of the 
remaining participants were part of the Nicotine/BMI group.  
All 14 of these study participants completed both the 7 day and 30 day follow-
ups.  The original study design required patients to return to the Urgent Care section of 
the Yale Emergency Department for the 7 day follow-up.  The patient would answer the 7 
day follow-up survey and have their peak flow measured along with their expired carbon 
monoxide (CO).  The expired CO was to verify the patient’s self reported smoking status.  
However, a significant number of participants were unable to return to the Emergency 
Department for this 7 day follow-up.  As a result, these 7 day follow-up contacts were 
done by phone.  The total number of patients who were contacted by phone to complete 
the 7 day follow-up was 5.  Therefore, the smoking status of the participants in the study 
is considered self reported.  
 Despite the lack of data for CO levels of the participants, most were able to 
provide a peak flow, as they had a peak flow meter at their home.  However, peak flow 
data obtained from the participants in the study is also considered self-report.  Also, there 
were 2 participants in the standard care group and 1 participant in the Nicotine/BMI 
group who were included in the full study, but were unable to provide a 7 day peak flow 
measurement.  
All 14 participants in the full study were contacted at least 30 days following their 
presentation to the Emergency Department with an acute asthma exacerbation.  They 
were asked to complete their 30 day follow-up questionnaire by phone. 
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The total enrollment in the study was well below the required 72, or n = 36 per 
group.  However, the statistical analysis was completed to look at the makeup of the 
participants enrolled in the study, as well as to determine if there were any statistically 
significant differences between the participants enrolled in the standard care group versus 
the participants enrolled in the Nicotine/BMI group.    
Looking at the number of cigarettes per day, as given by the participants on the 
initial smoking inventory that was collected the day that the patient presented to the ED 
with an asthma exacerbation, the mean number of cigarettes was not statistically 
significant. (NRT/BMI 18.6 ±  8.7, range 10-35; Standard Care 14.5 ± 5.3, range 10-21; 
p = 0.18) The smoking inventory also asked participants about the time, in minutes,  
between waking up and having their first cigarette of the day.  Again, these results were 
found to be not statistically significant. (NRT/BMI 16.5 ±   15.7, range 5-45; Standard 
Care 20.4 ±   16.9, range 5- 45; p = 0.50)  
Participants in the study were asked about other smokers in the home.  In the 
Nicotine/BMI group, 57% (n = 7) had at least one other smoker living with them.  Some 
had as many as 5+ other smokers living with them.  In the standard care group, 71% (n = 
7) had at least one other smoker living in the same home as they did.  Using the Fisher 
exact test, the calculated p-value was 0.5.  There is no statistical significance in the 
difference between groups.   
The next piece of data evaluated for comparison within the two experimental 
groups is the age at which study participants smoked their first cigarette.  There was no 
significant difference between the NRT/BMI group and the Standard Care group. 
(NRT/BMI 15.0 ±  3.2, range 9 – 20; Standard Care 14.1 ±  3.7, range 12 – 20; p = 0.53) 
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Closely associated with the age at first cigarette is the age at which participants first 
started smoking cigarettes on a daily basis.  There was also no significant difference 
between these values in the two groups. (NRT/BMI 16.3 ±  3.3, range 11-21; Standard 
Care 16.8  ±  3.6, range 12 – 24; p = 0.7)  
The next smoking demographics evaluated for statistical significance between the 
two groups was the number of years, in total, that the participants had been smoking 
cigarettes as well as the number of days per week that the participants smoked. These 
numbers were, again, not statistically significant.  (NRT/BMI 13.9 ±  6.9, range 5.5 – 25; 
Standard Care 9.3 ±  8.2, range 2 – 30; p = 0.25)  
The final smoking demographic looked at the number of days per week the 
participants would smoke.  In the Nicotine/BMI group, each of the participants smoked 7 
days per week.  In the standard care group, all but two of the participants smoked 7 days 
a week.  One participant smoked only 5 days per week and the final participant smoked 
only 2 days per week.  The means for the two groups were not found to differ by a 
statistically significant amount. (NRT/BMI 7 ±  0, range 7 -7; Standard Care 6.4 ±  1.5, 
range 2 – 7; p = 0.21)  
The next area of demographics to be analyzed looked at the Stage of Change.  
One of the criteria for participation in this study was that the patients be either in the 
contemplation or preparation stages of change as far as being ready to quit smoking.  This 
would ensure that patients were more mentally prepared to quit smoking.  The 
questionnaire asked if patients were contemplating quitting smoking in the next 30 days, 
the next 6 months or not at all.  In the Nicotine/BMI group, 100% (n = 7) were 
considering quitting smoking within the next 30 days and 0% (n = 0)  were considering 
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quitting in the next 6 months.  For the standard care group, 86% (n = 6) of the 
participants were considering quitting in the next 30 days and 14% (n = 1) of the patients 
were considering quitting in the next 6 months.  The Fisher exact test demonstrated a p-
value of  0.5. 
The final area of demographics to be analyzed was the severity of the asthma 
symptoms of the participants in the study.  Participants were asked to subjectively rate 
the severity of their asthma upon presenting to the Emergency Department.  The means 
of the two groups were found to be statistically similar. (NRT/BMI 6.1 ±   1.4, range 4 – 
8; Standard Care 6.6  9.1 , range 3 – 9; p = 0.56) . 
Overall, it appears that both the Nicotine/BMI group and standard care group 
were drawn from the same population of patients.  Although, there was wide variability 
in individual pieces of data collected, none of the smoking habit demographics or asthma 
symptom severities mean values were significantly different after statistical analysis.  













# Cig/Day 18.5 8.7 14.5 5.3 0.18 
Time (min) to 1st Cig 18.6 18.5 20.4 15.9 0.50 
Age 1st Cig 15.0 3.2 14.1 3.7 0.53 
Age Daily 16.3 3.3 16.8 3.6 0.70 
# Yrs Smoke 13.9 6.9 9.3 8.2 0.25 
Days/wk Smoke 7.0 0.0 6.4 1.5 0.21 
Asthma Severity (0-10) 6.1 1.4 6.6 1.9 0.56 
Table 2:  The data collected on all enrolled participants was broken down into the 
appropriate study groups, either Nicotine/BMI or Standard Care.  It includes the 
means, standard deviations, and the p-values that were calculated using the two-sided 












Because the number of participants that were lost to follow-up was so high in this 
study, an analysis and comparison of the characteristics of the participants who followed-
up versus those who didn’t was performed.  This was done to ensure that there were no 
statistically significant differences between the group that followed-up and the group that 
did not follow-up that may have contributed to the huge percentage that were lost to 
follow-up.   The results can be found in Tables 4 and 5 below. Overall, the only 
statistically significant difference was the age at first daily cigarette.  The group that did 
not follow-up had a mean of age 14.7 while the group that did follow-up had a mean age 
of 17.7. 
 
Characteristic % NRT/BMI % Standard Care P-Value 
 Preparation Stage of 
Change (Vs 
Contemplation) 
100 86 0.5 
Other Smokers in 
Home 
57 71 0.5 
Table 3: The data collected on all enrolled participants and separated into Nicotine/BMI 
or Standard Care.  It is the percentages of the listed characteristics for each group along 






























# Cig/Day 15.7 7.0 17.7 7.9 .53 
Time (min) to 1st Cig 19.1 18.4 16.7 12.3 .73 
Age 1st Cig 15.0 3.9 13.8 2.4 .41 
Age Daily 17.7 3.6 14.7 2.18 .041 
# Yrs Smoke 13.3 7.9 8.9 7.4 .26 
Days/wk Smoke 6.9 .53 6.4 1.6 .39 
Asthma Severity (0-10) 6.1 1.4 6.9 1.9 .29 
Characteristic Followed-Up Didn’t Follow-up P-Value 
Preparation Stage of 
Change 
93 56 0.054 
Other Smokers in 
the Home 
69 78 0.29 
Table 5: The data collected on all enrolled participants and separated into those who 
followed-up and those who were lost to follow-up.  It is the percentages of the listed 
characteristics for each group along with the p-values calculated using the fisher exact 
test. 
Table 4:  The data collected on all enrolled participants was broken down into the 
appropriate study groups, those that followed-up and those that did not.  It includes the 
means, standard deviations, and the p-values that were calculated using the two-sided 







In analyzing the first hypothesis: there will be a higher rate of smoking cessation 
among the asthmatics treated with Nicotine/BMI versus the standard care group, the 7 
day and 30 day quit rates were evaluated.  The statistical analysis was done by looking at 
the 14 patients who completed all phases of the study.  In the Nicotine/BMI group, only 2 
of the 7 participants, or 28.6%, had quit smoking after 7 days.  In the standard care group, 
3 of the 7, or 42.9%, had quit smoking.  However, using the one-sided Fisher exact test to 
examine the statistical significance of these findings, the calculated p-value was found to 
be 0.367.  Therefore, the findings are not considered statistically significant. 
Similar results were obtained by examining the 30-day quit rate.  In the case of 
the Nicotine/BMI group, again 2 of the 7 participants remained smoke free at 30 days.  
For the standard care group, there were also 2 of the 7.  It should be noted that one of the 
participants in the standard care group was still smoking at 7 days, but had quit at the 30 
day follow-up.  For the purposes of this study, the participant was still considered a 
smoker.  These results were 28.6% nonsmokers in each group and a p-value of 0.424. 
The second hypothesis was that patients in the Nicotine/BMI group would have 
greater improvement of their asthma symptoms than those in the standard care group.  
This was measured using the peak flow, number of return visits for asthma, medication 
requirements, and subjective monitoring of asthma symptoms. 
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First, the mean 7 day peak flow of the Nicotine/BMI group, using the data 
available, was not found to be statistically different. (NRT/BMI 308 ±  40.8, range 250 – 
375; Standard Care 325 ± 94.3, range 160 – 400; p = 0.7)  
Each of the participants was asked if they had to return to the emergency 
department for treatment of their asthma symptoms since their initial presentation and 
enrollment in the study at both the 7 and 30 day follow-ups.  In the Nicotine/BMI group, 
none of the participants required a return visit to the emergency department.  In the 
standard care group, there was one participant who required a single return visit to the 
emergency department during the 30 day course of their study participation. Using the 
Fisher exact test, this results in a p-value of 0.5. 
One of the medication requirements used to evaluate the improvement in asthma 
symptoms was the use of an inhaler by study test subjects.  Participants were asked on 
which days they required the use of their inhaler as a result of unexpected asthma 
symptoms during the course of their participation in this study.  These values were 
averaged out to a value representing the number of times per week that test subjects were 
requiring supplemental inhaler therapy for their asthma symptoms.  These results were 
not statistically significant. (NRT/BMI 2.15 ±  0.66, range 2-7; Standard Care 3.14 ±  
1.86, range 1-7; p = 0.52).  Please see Figure 1. 
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Finally, participants were asked to rate the severity of their asthma symptoms on a 
scale of 1-10 in the same manner as in the initial smoking and asthma questionnaire at 
both 7 and 30 days.  As expected, during the 7 day follow-up, 100% of the participants 
reported a lower severity of symptoms when compared to their initial subjective 
assessment while being treated in the Emergency Department. The mean values were, 
again, not statistically different. (NRT/BMI 2.5 ±  1.97, range 0-6; Standard Care 1.8 ±  
1.3, range 0 -3; p = 0.5)  The 30 day subjective assessment of subject’s asthma symptoms 
yielded similar results.  (NRT/BMI 2.33 ±  1.37, range 0 – 4; Standard Care 2.7 ±  1.8, 
range 0-5; p = 0.68)  
The final measure of the severity of asthma symptoms between the two groups 
was to look at the subjective improvement of symptoms of the two groups between the 7 
and 30 day follow-ups. These results were not statistically significant.   In the 
Figure 1: Weekly inhaler use for the two study groups. 
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Nicotine/BMI group, 2 test subjects reported improvement in the severity of their 
symptoms, while 5 reported that their symptoms either stayed the same or worsened over 
this time period.  In the standard care group, only 1 test subject reported that the severity 
of their asthma symptoms had improved, while 6 reported that their symptoms had either 
stayed the same or worsened.  Again, the p-value was calculated using the Fisher Exact 
test.  In this case, the p-value was calculated to be 0.5. 
 
Secondary Outcome 
Although the quit rates were not as high as expected, there are some data to 
suggest that even if the test subjects were unable to quit smoking cigarettes, they were 
able to at least cut down on the number of cigarettes smoked on a daily basis.  During 
both the 7 and 30 day follow-ups, participants were asked to quantify the number of 
cigarettes they smoked each day.  Because there is no way to measure the accuracy of the 
number of cigarettes reported by each of the participants, this data is all self-reported.  
However, in the Nicotine/BMI group, all 5 of the people who reported smoking since 
their presentation to the Emergency Department also reported a decrease in the number of 
daily cigarettes at 7 and/or 30 days by at least 25%  when compared to their initial 
smoking questionnaire.  Please see Figure 2.  In some cases, the decreases were fairly 
dramatic.  Two participants decreased their daily cigarette consumption by more than 
half.  When looking at the standard care group, only 3 of the participants that were unable 
to quit were able to decrease the number of cigarettes they were smoking on a daily basis 
by greater than 25%.  In fact, two of the participants in the standard care group actually 
increased the number of daily cigarettes.  Please see Figure 3. Again, statistical analysis 
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was performed using the one-sided Fisher Exact Test.  The result of this calculation was a 
p-value of 0.035.  In this case, the difference is statistically significant between the 






























Figure 2: Comparison of  the number of daily cigarettes at 
enrollment and follow-up of the patients enrolled in the 
Nicotine/BMI group who were unable to quit smoking during the 
study. 
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Because the NRT/BMI group was being treated with nicotine patches and 
lozenges, this group was also surveyed about side effects of the patch and lozenges along 
with actual use of the NRT provided.  Of the 7 participants in the NRT/BMI group, 2 
patients reported a side effect of a rash from using the nicotine patch.  Both participants 
were unable to continue use of the patch due to the discomfort of the rash.  One patient 
reported a dry mouth, but continued using the patch.   
Of the seven NRT/BMI participants, none of the patients used the patches 
provided for the full 30 days.  Two of the participants stopped within a few days due to 
the severity and discomfort of a rash.  Two participants used the patch for 3 days and then 
Figure 3: Comparison of the number of daily cigarettes at enrollment and  
30 day follow-up of the patients enrolled in the Standard Care group who 
were unable to quit smoking during the study. 
29 
started smoking again.  One patient used the patch for 2 weeks before stopping its use.  
One patient used the patch for three days and was then able to quit for the remaining 
period of the study and one patient used the patches for about 2 weeks and was also able 
to successfully quit for the study period of 30 days. 
Only one of the NRT/BMI participants reported using the lozenges on a regular basis.  
This patient used them for the first two weeks.  The remainder of the study group 
reported either no interest in using the lozenges or a bad taste that prevented them form 
using the lozenges. 
Discussion 
The purpose of this study was to examine a potential way to promote smoking 
cessation in the emergency department.  The study population, consisting of asthmatic 
smokers presenting to the emergency department with an acute exacerbation, was thought 
to be most susceptible to intervention.  Further, in order to qualify for the study, 
participants were required to already be in a state of mind to quit smoking.  In this case, 
the appropriate state of mind is defined as in the contemplation or preparation stage when 
given the Stage of Change Survey as described in earlier sections.  Furthermore, another 
goal of this study was to ultimately see an improvement in the severity of asthma 
symptoms for the patients who participated in the study and were able to successfully quit 
smoking.  
Overall, the results were encouraging.  Despite the small sample size, there was a 
statistically significant decrease in the number of daily cigarettes smoked by members of 
the NRT/BMI group when compared to the standard care group.  In fact 100% of the 
participants in the NRT/BMI group reported a lower number of daily cigarettes at the 7 or 
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30 day follow-up when compared to the number they reported upon joining the study at 
their presentation to the emergency department with an asthma exacerbation.  These 
included two members of the group who reported complete smoking cessation at the 30 
day follow-up.  In the standard care group, only 40% of the participants reported a lower 
number of daily cigarettes at either the 7 or 30 day follow-up.   
Although the data obtained indicates a potentially positive outcome from the 
study, the information used is based on self-reported numbers.  In the case of self-
reported data there is always the potential problem of bias on the part of the test subject.  
The participants were aware that the purpose of the study was to investigate ways to 
promote smoking cessation.  Also, the study participants were obviously aware of 
whether or not they were part of the Nicotine/BMI or standard care group.  These factors 
may have caused participants to underestimate the number of cigarettes they reported 
smoking at the 7 day follow-up visit or the 30 day phone follow-up. 
Despite the potential data problems from this aspect of the study, there is strong 
evidence that even a reduction in the number of cigarettes can have an eventual impact on 
respiratory health. One study promotes the use of an intermediate step in smoking 
cessation.  This allows patients to be able to first reduce the number of cigarettes they 
smoke gradually as a stepping stone to full smoking cessation.  Although there was no 
indication of improvements in morbidity or mortality, the study demonstrated that a 
successful reduction the amount of cigarettes provided motivation to proceed to full 
smoking cessation (43).    
A significant body of research demonstrates that smoking cessation improves 
outcomes in asthma.  Therefore, it is a good idea to promote any practice that will lead to 
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smoking cessation, even if it is only an intermediate step.  The benefits in outcomes 
measured in this study, such as severity of asthma symptoms, may not be directly 
affected by a decrease in cigarette consumption.  However, the increase in motivation 
provided by this reduction may eventually lead to complete abstinence from smoking.  
This will lead to measurable improvements in asthma outcomes.  Therefore, even a 
modest reduction in cigarette consumption may be seen as a positive outcome. 
Because of the extremely small sample size, there was no statistical significance 
to support the hypothesis that the Nicotine/BMI intervention was more effective than the 
current standard of care practiced in emergency departments for short term smoking 
cessation.  There was also no statistical evidence to support the second hypothesis that 
there would be improvement in asthma symptoms in those patients that were treated with 
the Nicotine/BMI intervention 
Statistical analysis of the make-up of both the Nicotine/BMI and standard care 
groups supports the fact that there was no significant difference in the two populations. 
Specific areas that were analyzed included, number of cigarettes smoked per day, years 
of smoking, age at first cigarette, age of first daily cigarette, time to first daily cigarette, 
days per week of smoking, peak flow on presentation to the emergency department, stage 
of change, and presence of other smokers in the household. 
Due to the fact that 39% of the participants were lost to follow-up, a separate 
statistical analysis of the initial data provided in the first survey was performed to see if 
there were any statistically significant differences in the two groups that may have led the 
participants to follow-up or not.  The only data that ended up being significant was the 
age at which the participants began smoking daily.  For the group that was lost to follow-
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up, the age was a younger 14.7 years old compared to 17.7 years old in the group that did 
follow-up.  However, there was no significant difference in the mean number of years 
that participants had been smoking.  Therefore, it may not have had any impact on 
whether or not participants were more likely to follow-up.  All other data points that were 
compared showed no significance and it is likely that the participants were drawn from 
similar populations. 
This study specifically targeted a short term quit rate.  In this case, 30 days.  Short 
term quit-rates may be a first step towards a longer term quit rate.  However, it is difficult 
to define a short term quit rate.  For example, there was one participant in this study who 
was still smoking at the 30 day follow-up, but managed to stop smoking the last 2 weeks 
leading up to the 30 –day follow-up.  Longer term follow-up research may help to clarify 
the impact of short term quitting demonstrated in this research project. 
 There is strong evidence that smoking cessation leads to improvement of asthma.   
There is also support for the idea that the emergency department is an appropriate place 
to initiate smoking cessation.  The emergency department has become the sole provider 
of healthcare to many patients and may be the only opportunity for a provider to promote 
the idea of smoking cessation.   Furthermore,  in many studies, nicotine replacement 
therapy has been shown to be an effective method of promoting smoking cessation.  The 
methods used in this study, specifically a combined regimen of NRT using the patch and 
lozenges, has even been shown to increase the rate of smoking cessation over 
monotherapy with NRT. (22) 
There was no evidence that the combined Nicotine/BMI therapy yielded a higher 
quit rate than the current standard of care after 7 days.  The effect, if any, is not strong 
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enough to be demonstrated with a small population size.  There are several reasons that 
this first hypothesis was not born out, especially given the extremely small sample size 
with which the calculations were performed.  The initial study design required sample 
sizes of n = 36 for both the Nicotine/BMI and standard care groups in order to achieve a 
power of 80%.  The number of test subjects enrolled in the study was n = 11 for the 
Nicotine/BMI group and n = 12 for the standard care group.  Therefore, the total number 
of enrollees was about 1/3 of what was needed to achieve power of 80%.    
Enrollment appears to have been a problem for several reasons.  The inclusion 
criteria for the study were fairly restrictive.  There were several factors about this 
emergency department population that made enrollment more of a challenge.  Firstly, the 
patients were automatically excluded if they were going to be admitted to the hospital.  
The population of patients for this hospital tend to be very sick, and therefore make 
discharging patients to home more difficult.  Secondly, patients must be proficient in 
spoken and written English.  There is a significant proportion of the emergency 
department population that speaks little or no English.  In this hospital it is 15% and may 
be even higher for asthma patients   There were some patients who presented to the 
emergency department with asthma exacerbations during the enrollment time that did not 
meet the criteria for minimum number of 10 cigarettes per day.  There were also a 
number of patients that were otherwise eligible for the study, but were not yet in the 
contemplation or preparation stage of change.  Therefore, over the 16 months that this 
portion of the study was ongoing, there was a limit to the number of eligible patients and 
enrollment was surprisingly low. 
34 
Although enrollment was a problem, follow-up was just as much of a problem.  
The original study design required that patients return to the Urgent Care section of the 
Emergency Department 7 days following their enrollment in the study.  Patients assigned 
to the Nicotine/BMI group would receive an additional supply of patches and lozenges, if 
desired.  All patients would have a repeat measure of their expired CO to confirm the 
self-reported smoking status as well as a repeat peak flow measurement to use as data for 
their asthma control.  In addition, patients answered a follow-up survey.   
A high percentage of patients, 39%, were lost to follow-up.  There were several 
issues concerning follow-up.  Firstly, many patients were not able to be contacted with 
the information they provided on the initial questionnaire.  Therefore, they were unable to 
be reminded about returning for their follow-up visits.  Secondly, it was not always 
convenient for patients to return to the emergency department due to job and/or family 
commitments.  Whenever possible, participants that were unable to make the trip back to 
the emergency department for follow-up were contacted by phone. 
As a result of patients lost to follow-up, the already small number of participants 
was decreased even further.  The final number of test subjects ended up being an n = 7 
for the Nicotine/BMI group and also n = 7 for the standard care group.   
One reason that the Nicotine/BMI group was not as successful as predicted in 
their smoking cessation may have been that this was one of their first smoking cessation 
attempts.  It is well documented that the average smoker requires multiple quit attempts 
before finally succeeding in a permanent abstinence from cigarettes.  The American Lung 
Association reports that it takes, on average, two to four attempts for a smoker to finally 
quit smoking.  The initial smoking inventory used as part of the enrollment in this study 
35 
did not address the quitting history of the participants.  This information may have been 
useful in determining the likelihood that this quit attempt would be successful.  However, 
it would not have been possible in the setting of this study to address the reasons for the 
failure of past attempts and/or set precautions into motion to prevent a similar relapse to 
smoking. 
The American Lung Association also recommends setting a “quit date”.  This 
allows patients to make arrangements at home to remove all smoking paraphernalia from 
the home and to prepare emotionally for smoking cessation.  Participants in this study 
were asked to quit smoking on the day that they presented to the emergency department.  
This may have contributed to the low efficacy of the NRT/BMI therapy.   
 Some studies suggest that although nicotine replacement therapy is an efficacious 
way to promote smoking cessation in general, there is no one type of nicotine 
replacement program that works best.  In fact, since smokers vary so widely in their 
smoking habits, personalities, and motivation, there is a need to tailor the nicotine 
replacement therapy to each smoker individually.  The protocol for this study had 
available only one dose (21 mg) of the nicotine patch along with the lozenges.  The 
patches were intended to supply a steady stream of nicotine while the lozenges were for 
additional cravings throughout the day.  Although this is a commonly utilized and 
efficacious combination, it did not take into consideration the patients that could not 
tolerate the lozenges.  Very few of the members of the Nicotine/BMI group reported 
using the lozenges and the most common reason given was the unpleasant taste.  This 
would leave the participants vulnerable to the additional cravings.   
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One study that was recently published dealt with the lack of long-term abstinence 
from smoking, even with the use of nicotine replacement.  This study suggested that one 
of the reasons for this lack of success was failure to tailor the therapy to an individual 
smoker’s specific needs, including pharmacologic requirements (39).   Tailoring nicotine 
replacement therapy may be more advantageous to promoting smoking cessation; and 
should be considered in future research.  
Although none of the data showed a clear trend either for or against the primary 
hypothesis, there are several reasons why the Nicotine/BMI group did not achieve a 
higher smoking cessation rate.  One reason for this may be the fact that not all members 
of the Nicotine/BMI group were able to come in for their 7 day follow-up, and therefore 
did not receive an additional supply of nicotine patches and lozenges.  Some of the 
participants may have realized that a 7 day supply would not be enough to help them 
maintain abstinence on a long term basis, even 30 days.  Some of the participants were 
later contacted by phone, but had already resumed smoking and were no longer interested 
in smoking cessation using nicotine replacement therapy. 
There are several factors important to the success of a smoking cessation attempt 
that were not addressed in this study as either part of the standard care or Nicotine/BMI 
group.  Although there is documentation to suggest the importance of these factors, it 
would not always have been practical or feasible to address these concerns in the 
emergency department setting.  Among these factors are some of the more intangible 
measures like motivation and other psychological factors.  Other factors include 
family/social support for the patient’s decision to quit smoking, removing temptations in 
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the patient’s home, work, and/or social environments, and follow-up phone calls and/or 
visits. 
One recent study looked at a population of hospitalized cardiology patients and 
the factors that contributed to successful smoking cessation (40).  Although the patients 
in this study were not hospital inpatients, they were in similar circumstances given the 
fact that they were being treated for a smoking related illness in an emergent setting and 
had the benefit of the “teachable moment”.  Both sets of patients are thought to be in a 
position that makes them more susceptible to the promotion of smoking cessation. 
The results of this study suggest that psychological factors, especially self-
efficacy and positive social influences were important in the patients who were able to 
successfully quit smoking (40).  Self-efficacy, or the belief that a person is capable of 
achieving smoking cessation, is not something that can be taught in a single emergency 
department encounter.  Furthermore, although certain family and/or friends may be with 
the patient in the emergency department, there is no way to control the patient’s full 
range of family and social interaction.  In fact, although this factor may be important for 
successful smoking cessation, there is not a significant amount of influence that any 
health care provider or setting can use on social contacts in order to help the patient quit 
smoking. 
Other studies also promote the idea that strong, positive family support for 
smoking cessation is vital to success for the patient (41).  In this study, 57% of the 
Nicotine/BMI group and 71% of the standard care group shared their home with other 
smokers.  One study followed 349 patients from a smoking cessation clinic and 
discovered that one of the biggest predictors of success in smoking cessation was positive 
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family support (41).  This indicates that a key factor that may be critically important in 
smoking cessation may not be susceptible to outside influence from healthcare 
professionals.   
This same article also discussed the fact that follow-up phone calls and/or visits 
were important to successful smoking cessation.  This is one area that may be possible to 
explore in the emergency department setting.  Once contact is established with a patient, 
it may be possible to periodically re-contact that individual to provide positive 
reinforcement and motivation.  However, this is generally outside the realm of emergency 
medicine.  It may be possible to refer patients to a smoking cessation clinic or program.  
More research could be done to compare the efficacy of the positive influences of follow-
up by a healthcare provider versus family/social support, if family/friends are unwilling 
or unable to provide the required support.   
There is also research to indicate that the temptation to relapse back to smoking is 
higher, not only without family/social support, but if there is smoking related 
paraphernalia in the home.  This may include ashtrays, lighters, or cigarette cases.  This 
equipment may become a trigger that causes an unexpected relapse.  Having other 
smokers in the same home make it difficult to remove the paraphernalia from the 
patient’s home.  There is also the idea that being around other smokers is a temptation all 
its own.  One study looking at smokers who attempted to quit after contacting a quitline, 
demonstrated that former smokers exposed to a higher number of temptations were far 
more likely to relapse within the first 6 months of an otherwise successful smoking 
cessation attempt (42).    
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Again, this may be one of the factors that is not practical or feasible to address 
completely in an emergency department setting.  However, it may be possible to at least 
mention to the patient that successful smoking cessation may depend on removing him or 
herself from temptation whenever possible.   Even if it may not be possible, it will 
provide the patient with a warning of a large potential pitfall and help the patient to at 
least be aware and perhaps motivate themselves in that manner in the face of inevitable 
temptation.  
The overall results of this study did not support either of the two proposed 
hypotheses, however, there were several limitations to this study that likely impacted the 
outcomes.  These included small study size, a large percentage lost to follow-up, and time 
and scope of practice limits on emergency department providers.  Improvements in 
patient enrollment and follow-up may help.  There were other intangible factors not taken 
into consideration in this study that may or may not be important to promote smoking 
cessation.  Although some of these factors are not within the scope of emergency 
department visits, making the patient aware of these factors and providing tips to use 
them in their own favor may also have a positive impact on smoking cessation. 
Asthma, along with many other diseases, can be directly impacted by the use of 
cigarettes.  It is important that health care providers in any setting, especially the 
emergency department devise ways to promote smoking cessation among their patients.    
Using nicotine replacement therapy along with the Brief Motivational Interview is one 
way.  Further research may impact the proven efficacy of these methods in the 
emergency department.  
40 
Characteristics of emergency department care continue to evolve as the healthcare 
system evolves.  There is a large percentage of the population for whom the emergency 
department is their only contact with the healthcare system and/or a healthcare provider.  
It is imperative that providers not only discover the smoking status of their asthma, and 
other, patients, but also that they devise a way to promote smoking cessation among this 
patient population. 
There are some things that can be done differently in future studies to improve the 
outcomes.  These may include using telephone follow-up exclusively.  Patients in the 
NRT/BMI group could be mailed their patches and lozenges.  This may improve the 
number of patients who follow-up because it will be much less of a hassle.  It may also be 
useful to use non-providers to enroll patients in the study.  The emergency department 
can be a very busy place and many potential subjects may not get enrolled due to time 
constraints placed on providers working in the emergency department.  There may also 
be room to allow for smokers of fewer daily cigarettes into the study group.  There are 
several doses of nicotine patches available.  It may be useful to have different doses 
provided for different levels of cigarette consumption.    
Although the outcomes of this study were not overwhelmingly successful, there is 
room for improvement in future studies based on the same theory.  There was one 
positive trend in the apparent reduction in the number of cigarettes smoked by members 
of the group that received nicotine replacement and counseling.  Smoking cessation 
promotion in the asthmatic population is vital to the care of these patients.  Continuing 
research in this area should focus on ways to help achieve this goal and ongoing 
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